Lista de obras - Dario Roccatello - Dominio Público Uruguay

8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study

scientific article published on 26 May 2012

A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment

artículo científico

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab

artículo científico publicado en 2018

Antiphospholipid Syndrome and the Kidney

artículo científico

Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review

artículo científico publicado en 2014

Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review

artículo científico publicado en 2017

Catastrophic antiphospholipid syndrome (CAPS).

artículo científico

Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria

artículo científico publicado en 2012

Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients

scientific article published on 13 February 2020

Common variable immunodeficiency: crossroads between infections, inflammation and autoimmunity

artículo científico publicado en 2012

Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls, and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy

scientific article published on 16 November 2020

Cytokine release pathway in mononuclear cells stimulated in vitro by dialysis membranes

artículo científico publicado en 2002

Daratumumab monotherapy for refractory lupus nephritis

artículo científico publicado en 2023

Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence

artículo científico publicado en 2017

GAPSS: the Global Anti-Phospholipid Syndrome Score

artículo científico publicado en 2013

Genetic factors associated with rheumatoid arthritis and systemic vasculitis: Evaluation of a panel of polymorphisms.

artículo científico publicado en 2009

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with A

artículo científico publicado en 2017

High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.

artículo científico publicado en 2017

High-titer Anti-aquaporin-4-IgG-associated Myelitis in Rhupus Syndrome

artículo científico publicado en 2012

How I treat patients with systemic sclerosis in clinical practice

artículo científico publicado en 2017

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients

scientific article published on 16 December 2019

Immunogenetics of complement in mixed cryoglobulinaemia

artículo científico publicado en 2016

Immunological Rare Diseases

artículo científico publicado en 2017

Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study.

artículo científico publicado en 2016

Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network

scientific article published on 14 September 2020

Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review

artículo científico publicado en 2016

Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology

artículo científico publicado en 2018

Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy

artículo científico publicado en 2011

Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis

scientific article published on 01 September 2011

Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review

artículo científico publicado en 2020

Lab-on-a-chip: Emerging analytical platforms for immune-mediated diseases ⬇️

artículo científico publicado el 6 de diciembre de 2012

Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement

scientific article published on 10 November 2020

Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression.

artículo científico publicado en 2012

Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis

artículo científico publicado en 2011

Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases

artículo científico publicado en 2012

Nailfold Capillaroscopy Patterns

artículo científico publicado en 2019

Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab

artículo científico publicado en 2022

Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome

artículo científico publicado en 2016

Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome

artículo científico publicado en 2017

Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation

artículo científico publicado en 2020

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort.

artículo científico publicado en 2017

P0244OVERTURNING THE CONVENTIONAL PYRAMID OF AL AMYLOIDOSIS MANAGEMENT: DARATUMUMAB ADMINISTERED AS MONOTHERAPY IN SEVERE PATIENTS WITH BIOPSY PROVEN RENAL INVOLVEMENT

artículo científico publicado en 2020

Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases

artículo científico publicado en 2014

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19

artículo científico publicado en 2020

Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy

artículo científico publicado en 2002

Radiotherapy in patients with HIV: current issues and review of the literature.

artículo científico publicado en 2017

Radiotherapy in patients with connective tissue diseases.

artículo científico publicado en 2016

Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials

artículo científico publicado en 2017

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study

scientific article published on 05 March 2019

Rheumatoid arthritis: Biological therapy other than anti-TNF.

artículo científico

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome.

artículo científico publicado en 2018

Rituximab as a therapeutic tool in severe mixed cryoglobulinemia

artículo científico publicado en 2008

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App

artículo científico publicado en 2022

The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study.

artículo científico publicado en 2017

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents

artículo científico publicado en 2017

The global anti-phospholipid syndrome score in primary APS.

artículo científico publicado en 2014

The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities

artículo científico publicado en 2020

The role of nail-videocapillaroscopy in early diagnosis of scleroderma

artículo científico publicado en 2012

Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring

scientific article published on 12 December 2019

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay

artículo científico publicado en 2016

Towards a novel target therapy for renal diseases related to a plasma cell dyscrasia: The example of AL amyloidosis

artículo científico publicado en 2020

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS

artículo científico publicado en 2019

Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.

artículo científico publicado en 2013

Upcoming biological therapies in systemic lupus erythematosus.

artículo científico

Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.

artículo científico publicado en 2015

Lista de obras de Dario Roccatello

8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study

A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab

Antiphospholipid Syndrome and the Kidney

Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review

Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review

Catastrophic antiphospholipid syndrome (CAPS).

Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria

Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients

Common variable immunodeficiency: crossroads between infections, inflammation and autoimmunity

Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls, and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy

Cytokine release pathway in mononuclear cells stimulated in vitro by dialysis membranes

Daratumumab monotherapy for refractory lupus nephritis

Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence

GAPSS: the Global Anti-Phospholipid Syndrome Score

Genetic factors associated with rheumatoid arthritis and systemic vasculitis: Evaluation of a panel of polymorphisms.

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with A

High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.

High-titer Anti-aquaporin-4-IgG-associated Myelitis in Rhupus Syndrome

How I treat patients with systemic sclerosis in clinical practice

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients

Immunogenetics of complement in mixed cryoglobulinaemia

Immunological Rare Diseases

Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study.

Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network

Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review

Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology

Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy

Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis

Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review

Lab-on-a-chip: Emerging analytical platforms for immune-mediated diseases ⬇️

Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement

Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression.

Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis

Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases

Nailfold Capillaroscopy Patterns

Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab

Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome

Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome

Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort.

P0244OVERTURNING THE CONVENTIONAL PYRAMID OF AL AMYLOIDOSIS MANAGEMENT: DARATUMUMAB ADMINISTERED AS MONOTHERAPY IN SEVERE PATIENTS WITH BIOPSY PROVEN RENAL INVOLVEMENT

Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19

Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy

Radiotherapy in patients with HIV: current issues and review of the literature.

Radiotherapy in patients with connective tissue diseases.

Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study

Rheumatoid arthritis: Biological therapy other than anti-TNF.

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome.

Rituximab as a therapeutic tool in severe mixed cryoglobulinemia

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App

The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study.

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents

The global anti-phospholipid syndrome score in primary APS.

The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities

The role of nail-videocapillaroscopy in early diagnosis of scleroderma

Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay

Towards a novel target therapy for renal diseases related to a plasma cell dyscrasia: The example of AL amyloidosis

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS

Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.

Upcoming biological therapies in systemic lupus erythematosus.

Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.